Industry revenue of »dispensing chemist in specialised stores« in Bulgaria 2011-2023
The Bulgarian pharmaceutical industry has emerged as one of the fastest growing sectors of the economy in the past few years, fuelled by the increased production of high quality medicines and attractive pricing strategies. Over the past few years, the county has made heavy investments to modernize production facilities and the entry of multinational players has further boosted industry growth. Revenues have risen from 925 million U.S. dollars in 2011 to over 1.6 billion U.S. dollars in 2019. Additionally, pharmaceutical exports have also risen over five-fold between 2012-2018, with majority of the revenue generated from medicament mixtures used in dosages.
Tchaikapharma to start production of medicines for Covid-19 treatment
Tchaikapharma, one of the leading drug manufactures in the country has started production of two drugs, MoriVir and GraVir for the treatment of the novel coronavirus disease, as the number of cases in the country continue to rise. It expects to produce 5,000 packs of MoriVir and 20,000 packs of GraVir in May. Once granted market authorization, they will be distributed to pharmacy networks across the country.
Tchaikapharma to start production of medicines for Covid-19 treatment
Tchaikapharma, one of the leading drug manufactures in the country has started production of two drugs, MoriVir and GraVir for the treatment of the novel coronavirus disease, as the number of cases in the country continue to rise. It expects to produce 5,000 packs of MoriVir and 20,000 packs of GraVir in May. Once granted market authorization, they will be distributed to pharmacy networks across the country.
